Industry & Policy News

[HHMI] The Howard Hughes Medical Institute announced today that 26 of the nation’s leading scientists have been named HHMI Investigators. HHMI will invest more than $300 million in this newest cohort over the next seven years, enabling each Investigator to push the boundaries of science.

[Pork Business] Though the reason is unknown, castrated male swine experience nearly double the mortality rate of females, explains Sydney Puda, a student at Michigan State University College of Medicine. Puda is one of 15 students who have been named as part of the sixth cohort of the Foundation for Food & Agriculture Research  Veterinary Student Research Fellowship (FFAR Vet Fellows).

[Astellas Pharma Inc.] Astellas Pharma Inc. and Faculty of Medicine, Osaka University announced that Astellas Institute for Regenerative Medicine, Universal Cells, and Osaka University will collaborate to develop innovative PSC-derived cartilage organoid cell therapy for the treatment of intervertebral disc degenerative disease.

[OS Therapies, Inc. (BusinessWire)] OS Therapies, Inc. announced positive data from a Phase I clinical trial of OST-HER2 in patients with HER2-expressing solid tumors in breast cancer and other cancers.

[Conquer Cancer] Conquer Cancer®, the ASCO Foundation, in collaboration with Twisted Pink, has awarded the Twisted Pink Metastatic Breast Cancer Impact Award to Dr. Ashley  Schreier for her work studying the impact of immunotherapies on metastatic triple negative breast cancer—the most advanced stage of the disease.

[Harvard Medical School] Five researchers from Harvard Medical School have been named among 26 new HHMI Investigators by the Howard Hughes Medical Institute (HHMI).